CytoSorbents Corporation (CTSO)

[orangecat]

You are commenting from the investor audience. He also has to speak to the scientific and medical audience. That audience includes the FDA. REFRESH I had a physician that lead the study and they likely played a big role in the release of data. Stepping lightly with hype of drug/device when heading towards an FDA meeting for a pivotal trial has no downside for the company or long term investor. Looking for a quick buck, move along.